Disclosure 0001104659-26-113279-5

SEC FORM 4

$1,785,593.15

Protagonist Therapeutics, Inc (PTGX)

Sale of 12,595 shares at $141.77 per share.

Reporting Person Ali Asif · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 30, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001104659-26-113279 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Protagonist Therapeutics, Inc (PTGX)." Disclosed 2026-10-02. https://desqlong.com/cards/0001104659-26-113279-5 (retrieved 2026-10-03).